Patents by Inventor Mary Relling

Mary Relling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genotyping Assay to Predict Gamma Glutamyl Hydrolase (GGH) Activity
    Publication number: 20120178087
    Abstract: Single nucleotide polymorphisms (SNPs) in the gene encoding gamma glutamyl hydrolase (GGH) associated with reduced GGH activity are disclosed. The primary SNP is a change from a cytosine to a thymine at a position corresponding to nucleotide 511 of Genbank sequence accession no. NM 003878. Methods and kits for detecting these SNPs are provided, along with primers useful in detecting these SNP and for amplifying portions of the GGH gene containing these SNPs.
    Type: Application
    Filed: February 20, 2012
    Publication date: July 12, 2012
    Applicant: St. Jude Children's Research Hospital, Inc.
    Inventors: William Edward Evans, Mary Relling, Qing Cheng
  • Genotyping Assay to Predict Gamma Glutamyl Hydrolase (GGH) Activity
    Publication number: 20100291574
    Abstract: Single nucleotide polymorphisms (SNPs) in the gene encoding gamma glutamyl hydrolase (GGH) associated with reduced GGH activity are disclosed. The primary SNP is a change from a cytosine to a thymine at a position corresponding to nucleotide 511 of Genbank sequence accession no. NM 003878. Methods and kits for detecting these SNPs are provided, along with primers useful in detecting these SNP and for amplifying portions of the GGH gene containing these SNPs.
    Type: Application
    Filed: April 23, 2010
    Publication date: November 18, 2010
    Inventors: WILLIAM EDWARD EVANS, MARY RELLING, QING CHENG
  • Genotyping assay to predict gamma glutamyl hydrolase (GGH) activity
    Patent number: 7741032
    Abstract: Single nucleotide polymorphisms (SNPs) in the gene encoding gamma glutamyl hydrolase (GGH) associated with reduced GGH activity are disclosed. The primary SNP is a change from a cytosine to a thymine at a position corresponding to nucleotide 511 of Genbank sequence accession no. NM 003878. Methods and kits for detecting these SNPs are provided, along with primers useful in detecting these SNP and for amplifying portions of the GGH gene containing these SNPs.
    Type: Grant
    Filed: July 8, 2004
    Date of Patent: June 22, 2010
    Assignee: St. Jude Children's Research Hospital, Inc.
    Inventors: William Edward Evans, Mary Relling, Qing Cheng
  • Genotyping assay to predict gamma glutamyl hydrolase (GGH) activty government interest
    Publication number: 20060008811
    Abstract: Single nucleotide polymorphisms (SNPs) in the gene encoding gamma glutamyl hydrolase (GGH) associated with reduced GGH activity are disclosed. The primary SNP is a change from a cytosine to a thymine at a position corresponding to nucleotide 511 of Genbank sequence accession no. NM 003878. Methods and kits for detecting these SNPs are provided, along with primers useful in detecting these SNP and for amplifying portions of the GGH gene containing these SNPs.
    Type: Application
    Filed: July 8, 2004
    Publication date: January 12, 2006
    Inventors: William Evans, Mary Relling, Qing Cheng